These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11439689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Heart attack: what is your risk?
    Am Fam Physician; 2010 Aug 01; 82(3):275. PubMed ID: 20672792
    [No Abstract] [Full Text] [Related]

  • 3. National Heart, Lung, and Blood Institute halts part of antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
    SoRelle R.
    Circulation; 2000 Mar 28; 101(12):E9025. PubMed ID: 10736305
    [No Abstract] [Full Text] [Related]

  • 4. Meet the cholesterol busters.
    Healy B.
    US News World Rep; 2000 Mar 28; 136(10):54. PubMed ID: 15069903
    [No Abstract] [Full Text] [Related]

  • 5. Hypertension & high cholesterol: a dangerous synergy.
    Trottier DJ, Kochar MS.
    Am J Nurs; 1992 Nov 28; 92(11):40-3. PubMed ID: 1485630
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Reduction of cholesterol and myocardial infarction. Big differences between different groups when it comes to the therapeutic effect].
    Håkansson J.
    Lakartidningen; 1997 Dec 03; 94(49):4619, 4622-3. PubMed ID: 9445934
    [No Abstract] [Full Text] [Related]

  • 11. [Cardiology 2008].
    Hoppe UC, Erdmann E.
    Dtsch Med Wochenschr; 2008 Jun 03; 133(25-26):1341-3. PubMed ID: 18553258
    [No Abstract] [Full Text] [Related]

  • 12. [CBO guideline 'high blood pressure' (revision)].
    de Bruijckere PA.
    Ned Tijdschr Geneeskd; 2002 Mar 02; 146(9):439; author reply 439. PubMed ID: 11901947
    [No Abstract] [Full Text] [Related]

  • 13. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Düsing R.
    Dtsch Med Wochenschr; 2003 Jan 31; 128(5):214-6. PubMed ID: 12557115
    [No Abstract] [Full Text] [Related]

  • 14. [CBO guideline 'high blood pressure' (revision)].
    Polak BC.
    Ned Tijdschr Geneeskd; 2002 Mar 02; 146(9):439; author reply 439-40. PubMed ID: 11901948
    [No Abstract] [Full Text] [Related]

  • 15. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers DG, Lee KW, Lip GY.
    J Hum Hypertens; 2003 Jun 02; 17(6):367-72. PubMed ID: 12764397
    [No Abstract] [Full Text] [Related]

  • 16. The challenge of treatment.
    Lipold AG.
    Bus Health; 2001 Dec 02; 19(12 Suppl A):18-21. PubMed ID: 11799638
    [No Abstract] [Full Text] [Related]

  • 17. Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension.
    Rdzanek A, Filipiak KJ, Karpiński G, Grabowski M, Opolski G.
    Int J Cardiol; 2006 Jun 16; 110(2):175-8. PubMed ID: 16198012
    [Abstract] [Full Text] [Related]

  • 18. The Conduit Artery Functional Endpoint (CAFE) study in ASCOT.
    Williams B, O'Rourke M, Anglo-Scandinavian Cardiac Outcomes Trial.
    J Hum Hypertens; 2001 Aug 16; 15 Suppl 1():S69-73. PubMed ID: 11685915
    [No Abstract] [Full Text] [Related]

  • 19. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E, Giral P, Tellier P.
    Circulation; 2003 Jul 01; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract] [Full Text] [Related]

  • 20. How to beat back a heart attack? With swift and aggressive counterpunching.
    Comarow A.
    US News World Rep; 2001 Jan 15; 130(2):51. PubMed ID: 11191962
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.